Recruiting fMRI and Opioid Abstinence NCT06651333 Conditions Chemically-Induced Disorders, Disease Attributes, Drug Use Disorder, +11 more Locations The APT Foundation — New Haven, Connecticut, United States View Trial Details
Completed N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use NCT04627922 Conditions Cannabis Use, Chemically-Induced Disorders, Drug Use Disorder, +4 more Locations San Francisco Veterans Affairs Medical Center — San Francisco, California, United States View Trial Details
Completed Brief Contextual-Behavioral vs Twelve-Step Intervention for Emotion Regulation in Substance Use: Pilot Study NCT07337733 Conditions Alcohol Use Disorder, Alcohol-Related Disorders, Alcoholism, +11 more Locations Comunidad Terapéutica Under The Tree — Ajijic, Jalisco, Mexico View Trial Details
Completed Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) NCT00798538 Conditions Buprenorphine, Chemically-Induced Disorders, Drug Abuse, +12 more Locations Yale AIDS Program — New Haven, Connecticut, United States View Trial Details
Completed Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth NCT01442753 Conditions Alcohol Drinking, Alcohol Use Disorder, Alcohol-Related Disorders, +10 more Locations University of Minnesota — Minneapolis, Minnesota, United States View Trial Details
